- hepatocellular cancer;
- non-alcoholic fatty liver disease;
- chemotherapy induced liver injury;
- pancreatic cancer;
- colorectal liver metastases
Helen graduated from Nottingham Medical school in 1990, moving shortly afterwards to Newcastle under the mentorship of Professor Oliver James. She completed a PhD studying cell signaling pathways in liver fibrosis and then worked as a post-doctoral scientist with Professor Scott Friedman at Mount Sinai Medical School in New York, studying aspects of the molecular pathogenesis of cancers.
Presently she is Professor of Liver Cancer in the Northern Institute for Cancer Research and is the clinical lead for the care of patients with hepatocellular carcinoma in Northern England. She has been a scientific committee member for the British Association for Cancer Research and the European Association for Study of the Liver. She is an active member of the EASL Education Committee and the HCC-UK Committee.
Professor Reeve’s main research focus is on primary liver cancer in patients with NAFLD and in the development of clinically relevant biomarkers. She also has a keen interest in the promotion of education and training of young scientific investigators and clinical researchers. She has a program grant from Cancer Research UK (CRUK) centred on exploring the roles of neutrophils in liver cancer. She is also the PI for the recent Liver Cancer focused Accelerator award, jointly funded by CRUK, FC AECC and AIRC entitled ‘HUNTER: Hepatocellular Carcinoma Expediter Network’.